Articles From: Bristol-Myers Squibb Signs Exclusive Option Agreement to Acquire Galecto Biotech AB and Its Novel Galectin-3 Inhibitor in Development for Idiopathic Pulmonary Fibrosis to Finra Fines 10 Banks Over Their Pursuit of an IPO's Business -- 5th Update


Bristol-Myers Squibb Company (NYSE:BMY) and Galecto Biotech AB today announced that the companies, together with the Galecto shareholders, have entered into an agreement that provides Bristol-Myers Squibb the exclusive option to acquire Galecto Biotech AB and gain worldwide rights to its lead asset TD139, a novel inhaled inhibitor of galectin-3 in Phase 1 development for the treatment of idiopathic pulmonary fibrosis (IPF) and other pulmonary fibrotic conditions.
Sign-up for Bristol-Myers Squibb Signs Exclusive Option Agreement to Acquire Galecto Biotech AB and Its Novel Galectin-3 Inhibitor in Development for Idiopathic Pulmonary Fibrosis investment picks
OpenCL, ISO 26262 and AUTOSAR Solutions Help Cut Design Cycle Times in Half SAN JOSE, Calif.
Sign-up for Altera Demonstrates Automotive Embedded System Solutions that Increase Design Productivity at SAE Convergence 2014 investment picks
VANCOUVER, British Columbia, Oct.
Sign-up for Tekmira Presents Results of Preclinical Studies With Hepatitis B Therapeutic investment picks
2014/11/12
By Tatyana Shumsky Small investors are pouring money into silver, which has seen prices plunge to a four-year low.
Sign-up for UPDATE: Want to invest in silver? Read this first investment picks
2014/11/20
Leading Mobile Media Partners Authorized to Effectively Tag and Measure Mobile Ad Campaigns In-App RESTON, Va.
Sign-up for comScore Launches Authorized Tagging Partners Program for vCE Mobile to Measure Campaign Performance in Mobile Campaigns investment picks
2014/11/17
GE Antares, a unit of GE Capital, announced today it is serving as administrative agent on a $93 million senior secured credit facility to support the recent acquisition of Qualitor, Inc. by Wellspring Capital Management.
Sign-up for GE Antares Capital Finances Wellspring Capital Management’s Acquisition of Qualitor, Inc. investment picks
2014/11/21
It’s the most wonderful time of the year and Papa John’s is getting into the holiday spirit.
Sign-up for Papa John’s Kicks off the Holiday Season with the NEW Philly Cheesesteak Pizza and the NEW Red Kettle Cookie investment picks
2014/12/5
By Ted Mann, Joann S.
Sign-up for UTC's Boss Sails Away After Board Questions a Trip investment picks
2014/11/24
By Ted Mann And Angela Chen United Technologies Corp.
Sign-up for United Technologies CEO Chenevert Abruptly Steps Down -- 3rd Update investment picks
2014/11/24
By Ted Mann And Angela Chen United Technologies Corp.
Sign-up for United Technologies CEO Chenevert Abruptly Steps Down -- 4th Update investment picks
2014/11/25
By Ted Mann United Technologies Corp.
Sign-up for New United Technologies Chief Faces Tough Challenges investment picks
2014/12/11
By Ted Mann United Technologies Corp.'s new chief, Greg Hayes, is hunting for a major acquisition and is open to changing a portfolio that includes Otis elevators, Black Hawk helicopters and Carrier air-conditioning systems.
Sign-up for United Technologies CEO Hunting for Major Acquisition investment picks
NEW BRUNSWICK, N.J. , Sept.
Sign-up for Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results investment picks
Accelerates transformation of AMAG to a Profitable, Multi-Product Specialty Pharmaceutical Company Adds FDA-Approved Therapy Makena® and Complementary Commercial Platform to AMAG Portfolio Projected Pro Forma Combined 2015 Revenues of $350 million and Estimated Annual Cost Synergies of at least $20 million Transaction Expected to be Immediately Accretive to Adjusted Earnings Per Share Conference Call Today at 8am ET to Discuss Transaction WALTHAM, Mass., Sept.
Sign-up for AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business investment picks
2014/10/7
American Financial Group, Inc. (NYSE/NASDAQ: AFG) expects to release its 2014 third quarter results after 5:00 pm (ET) on Tuesday, October 28, 2014.
Sign-up for American Financial Group, Inc. Announces Its Conference Call and Webcast to Discuss 2014 Third Quarter Results investment picks
2014/12/11
By Telis Demos And Alexandra Scaggs Citigroup Inc., Goldman Sachs Group Inc. and eight other securities firms were fined a total of $43.5 million by regulators who said the companies offered favorable stock research in hopes of winning underwriting business in an initial public offering by Toys "R" Us Inc. The overall fines are believed to be among the biggest in a single case since the 2003 research settlement that barred research analysts from participating in IPO pitches because of potential conflicts of interest.
Sign-up for Finra Fines 10 Banks Over Their Pursuit of an IPO's Business -- 5th Update investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Bristol-Myers Squibb Signs Exclusive Option Agreement to Acquire Galecto Biotech AB and Its Novel Galectin-3 Inhibitor in Development for Idiopathic Pulmonary Fibrosis to Finra Fines 10 Banks Over Their Pursuit of an IPO's Business -- 5th Update
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent